Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001415889-24-022862 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Tessari Eben | COO | F - Tax | $26.74 | -1,899 | 123.1K | -2% | -$50.8K |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | +6,463 | 125.1K | +5% | $0 |
| DM | 2024-09-04 | 2024-09-01 | KNSA | Tessari Eben | COO | A - Grant | $0.00 | +43.3K | 36.3K | New | $0 |
| DM | 2024-09-04 | 2024-09-01+ | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -6,463 | 5,452 | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2024-09-02 | F | D | 577 | $26.74 | 124,475 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2024-09-01 | F | D | 1,322 | $26.74 | 123,088 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2024-09-01 | M | A | 4,499 | — | 124,410 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 4 | Common | Class A Ordinary Share | 2024-09-02 | M | A | 1,964 | $0.00 | 125,052 | D | — | — | |
| 5 | Derivative | Restricted Share Unit | 2024-09-01 | A | A | 6,981 | $0.00 | 6,981 | D | — · — to — | 6,981 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024. |
| 6 | Derivative | Share Option | 2024-09-01 | A | A | 36,300 | $0.00 | 36,300 | D | $26.74 · — to 2034-08-31 | 36,300 Class A Ordinary Share | (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024. |
| 7 | Derivative | Restricted Share Unit | 2024-09-02 | M | D | 1,964 | $0.00 | 1,964 | D | — · — to — | 1,964 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021. |
| 8 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 1,773 | $0.00 | 5,318 | D | — · — to — | 1,773 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023. |
| 9 | Derivative | Restricted Share Unit | 2024-09-01 | M | D | 2,726 | $0.00 | 5,452 | D | — · — to — | 2,726 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F4) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |